PRELUDE CAPITAL MANAGEMENT, LLC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 55 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2021$28,000
-73.8%
28,489
-70.8%
0.00%
-66.7%
Q2 2021$107,000
+2575.0%
97,590
+1674.4%
0.00%
Q3 2020$4,000
-98.8%
5,500
-89.8%
0.00%
-100.0%
Q1 2014$343,000
+19.1%
54,000
+20.0%
0.05%
-4.2%
Q4 2013$288,00045,0000.05%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
A.R.T. Advisors, LLC 20,419$16,0000.09%
Maven Securities LTD 1,000,000$795,0000.07%
Verdence Capital Advisors LLC 88,382$69,0000.02%
Hayden Royal, LLC 26,000$20,0000.01%
GSA CAPITAL PARTNERS LLP 55,752$44,0000.01%
Qube Research & Technologies Ltd 519,063$407,0000.01%
Virtu Financial LLC 39,683$31,0000.01%
Global Strategic Investment Solutions, LLC 23,000$18,0000.01%
Jacobi Capital Management LLC 25,000$20,0000.00%
RVW Wealth, LLC 19,000$15,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders